BioNTech SE (BNTX) Research & Development (2018 - 2025)
Historic Research & Development for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$660.3 million.
- BioNTech SE's Research & Development fell 925.49% to -$660.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 billion, marking a year-over-year decrease of 150.79%. This contributed to the annual value of -$2.4 billion for FY2024, which is 2555.73% down from last year.
- Latest data reveals that BioNTech SE reported Research & Development of -$660.3 million as of Q3 2025, which was down 925.49% from -$576.3 million recorded in Q2 2025.
- BioNTech SE's Research & Development's 5-year high stood at -$242.2 million during Q2 2021, with a 5-year trough of -$660.3 million in Q3 2025.
- Moreover, its 5-year median value for Research & Development was -$520.1 million (2022), whereas its average is -$467.9 million.
- In the last 5 years, BioNTech SE's Research & Development crashed by 10136067880.9% in 2021 and then soared by 846.13% in 2025.
- Over the past 5 years, BioNTech SE's Research & Development (Quarter) stood at -$310.6 million in 2021, then plummeted by 67.46% to -$520.1 million in 2022, then dropped by 19.53% to -$621.7 million in 2023, then dropped by 5.16% to -$653.8 million in 2024, then dropped by 1.0% to -$660.3 million in 2025.
- Its last three reported values are -$660.3 million in Q3 2025, -$576.3 million for Q2 2025, and -$552.9 million during Q1 2025.